Testing effectiveness (Phase 2)Looking for participantsNCT05272709What this trial is testingTT-702 in Patients With Advanced Solid Tumours.Who this might be right forAdvanced Solid Tumors Cancer Research UK 60
Testing effectiveness (Phase 2)Study completedNCT01971034What this trial is testingTreatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.Who this might be right forPancreatic Adenocarcinoma Advanced or Metastatic Instituto do Cancer do Estado de São Paulo 41
Large-scale testing (Phase 3)Study completedNCT02043288What this trial is testingCombination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic CancerWho this might be right forPancreatic Neoplasms Orient Europharma Co., Ltd. 310
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07784374What this trial is testingA Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 Monotherapy in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D MutationWho this might be right forPancreatic Cancer Genfleet Therapeutics (Shanghai) Inc. 120
Testing effectiveness (Phase 2)Study completedNCT00053924What this trial is testingPerifosine in Treating Patients With Advanced Pancreatic CancerWho this might be right forPancreatic Cancer University Health Network, Toronto
Testing effectiveness (Phase 2)Looking for participantsNCT06850623What this trial is testingAcoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic CancerWho this might be right forLocally Advanced Pancreatic Adenocarcinoma EXACT Therapeutics AS 25
Not applicableActive Not RecruitingNCT04395469What this trial is testingFAZA PET/MRI PancreasWho this might be right forPancreatic Adenocarcinoma Non-resectableLocally Advanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer University Health Network, Toronto 20
Testing effectiveness (Phase 2)UnknownNCT02959151What this trial is testingChimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver MalignancyWho this might be right forCarcinoma, HepatocellularPancreatic Cancer MetastaticColorectal Cancer Metastatic Shanghai GeneChem Co., Ltd. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07301229What this trial is testingA Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic CancerWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC) Shanghai Henlius Biotech 100
Not applicableStudy completedNCT04560270What this trial is testingCIrculating Tumor DNA for Monitoring Response to First Line Chemotherapy in Unresectable PANcreatic CancerWho this might be right forPancreatic CancerCirculating Tumor DNAKRAS Mutation-Related Tumors Poitiers University Hospital 69
Not applicableLooking for participantsNCT05475366What this trial is testingPersonalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic SignaturesWho this might be right forCarcinoma, Pancreatic DuctalPrognosis Institut Curie 85
Testing effectiveness (Phase 2)Study completedNCT00089024What this trial is testingCombination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic CancerWho this might be right forPancreatic Cancer University of Nebraska 29
Early research (Phase 1)Active Not RecruitingNCT03257761What this trial is testingGuadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder CancerWho this might be right forExtrahepatic Bile Duct Adenocarcinoma, Biliary TypeGallbladder Adenocarcinoma, Biliary TypeMetastatic Pancreatic Adenocarcinoma+25 more University of Southern California 55
Not applicableStudy completedNCT03869294What this trial is testingGS Regimen as the First-line Chemotherapy in Chinese Advanced PC PatientsWho this might be right forPancreatic CancerChemotherapy EffectChemotherapeutic Toxicity Zhejiang University 96
Early research (Phase 1)Not Yet RecruitingNCT06217666What this trial is testingStudy Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)Who this might be right forPancreatic Adenocarcinoma Haoming (Carl) Qiu 24
Early research (Phase 1)Study completedNCT01839981What this trial is testingCPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more Wake Forest University Health Sciences 10
Testing effectiveness (Phase 2)Ended earlyNCT00613730What this trial is testingAdenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary EndpointWho this might be right forCancer of PancreasCancer of the PancreasPancreas Cancer+1 more Amgen 3
Testing effectiveness (Phase 2)Ended earlyNCT02921737What this trial is testingTAS-102 (Lonsurf) in Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma Post First Line Chemotherapy (UF-STO-PANC-003)Who this might be right forPancreatic Cancer University of Florida 7
Testing effectiveness (Phase 2)Study completedNCT00016965What this trial is testingBMS-247550 in Treating Patients With Advanced Pancreatic CancerWho this might be right forPancreatic Cancer SWOG Cancer Research Network
Testing effectiveness (Phase 2)Looking for participantsNCT03556228What this trial is testingVMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaWho this might be right forHead and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more VM Oncology, LLC 242